… In non-smallcell lung cancer a phase-II trial has tested the combination of chemotherapy
and celecoxib in advanced … TRIBUTE – A phase III trial of erlotinib (OSI-774) combined with …

… Pemetrexed and Erlotinib are widely used as maintenance therapy for advanced non-small
cell lung cancer [7, 8]; … To the best of our knowledge, no previous literature has reported the …

… is often dysregulated in non–small-cell lung cancer (NSCLC). … Celecoxib dose was based
on our prior observations in lung … by combining celecoxib with the EGFR inhibitor erlotinib in …

… non–small cell lung cancer cell lines (13). … study investigated the optimal biological dose
of celecoxib and reported that 600 mg bid was the preferred dose in combination with erlotinib (…

… , a phase I/II trial combining bevacizumab with erlotinib in … combined Celecoxib with
Gefitinib in 11 patients with stage IV … : state of the art and development of new biologic agents. …

… along with Erlotinib in advanced lung cancer was 600mg to be taken twice … Combining
sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in …

… celecoxib, a selective cyclooxygenase 2 inhibitor with antiangiogenic activity is being tested
in combination with erlotinib in a phase II study … of the biologically optimal dose. Should we …

… A phase I trial to determine the optimal biological dose of celecoxib when combined with
erlotinib in advanced non-small cell lung cancer. Clin …

… and biologic properties of individual lung cancers which has … alone and another trial in which
erlotinib is given as maintenance … ) trial is a prospective phase II feasibility study combining …

… of docetaxel and the specific COX-2 inhibitor celecoxib. … -agent and combination therapy
in nonsmall cell lung cancer. … erlotinib in patients with recurrent non-small cell lung cancer (…